Mycamine — CareFirst (Caremark)
treatment of same infections without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months
Initial criteria
- limitations: safety and effectiveness not established for treatment of candidemia with meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months
- not adequately studied in endocarditis, osteomyelitis, and meningoencephalitis due to Candida
- efficacy not established against infections caused by fungi other than Candida